𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitative serum levels of pregnancy associated α2-globulin in patients with benign and malignant tumours

✍ Scribed by G. N. Than; I. F. Csaba; D. G. Szabó; N. J. Karg; P. F. Novák

Publisher
Springer
Year
1975
Tongue
English
Weight
332 KB
Volume
218
Category
Article
ISSN
0003-9128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum levels of soluble tumor-necrosis-f
Serum levels of soluble tumor-necrosis-factor receptors in patients with benign and malignant HPV-associated anogenital lesions
✍ Magdalena Malejczyk; Jaroslaw Jóźwiak; Anna Osiecka; Piotr I. Roszkowski; Walent 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 83 KB 👁 2 views

The levels of type-I and type-II soluble TNF-␣ receptors (sTNF-Rs) were evaluated in sera from patients with various human-papillomavirus-(HPV)-associated benign and malignant anogenital lesions using specific enzyme-linked immunobiological assays. In patients with benign HPV6/11-associated condylom

Development of a radioimmunoassay for pr
Development of a radioimmunoassay for pregnancy-specific beta1-globulin and its measurement in serum of patients with trophoblastic and non-trophoblastic tumours
✍ Yu.S. Tatarinov; A. V. Sokolov 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 French ⚖ 493 KB

## Abstract Levels of human pregnancy‐specific or trophoblast‐specific beta~1~‐globulin (TBG) were measured by double‐antibody radioimmunoassay (RIA) in 103 patients with trophoblastic tumours and in 114 patients with a variety of non‐trophoblastic tumours. The sensitivity of RIA for TBG was about

Serum trypsinogen-2 and trypsin-2-α1-ant
Serum trypsinogen-2 and trypsin-2-α1-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas
✍ Johan Hedström; Caj Haglund; Reijo Haapiainen; Ulf-Håkan Stenman 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 527 KB

Serum concentrations of trypsinogen-2 and trypsin-2-a,antibypsin (trypsin-2-AAT) were determined in I45 patients with malignant and 61 with benign digestive-tract diseases. The validity of these tests for detection of cancer was compared with that of CA19-9 and CEA. Elevated levels of trypsinogen-2